A reproductive well being start-up run by one in every of Britain’s most distinguished enterprise capitalists has swooped on one in every of its friends amid rising demand from giant corporations for the availability of fertility and different sexual health-related advantages to their workforces.
Sky Information understands that Fertifa, which is run by Eileen Burbidge, one in every of Britain’s most distinguished enterprise capitalists, has agreed a deal to purchase Juniper, a two-year-old London-based firm which gives reproductive medical insurance.
Sources stated the deal – price an undisclosed sum – could be introduced publicly on Thursday.
Cash newest: Inflation jumps by more than expected
It’ll present recent proof of the accelerating consolidation of an space of healthcare which has gained growing prominence as a part of corporations’ worker advantages packages lately.
Fertifa counts Meta – the proprietor of Fb, Instagram and WhatsApp – amongst its purchasers, together with different blue-chip companies such because the non-public fairness agency Hg Capital, H&M, Lululemon, MoFo, House NK and Virgin Group.
The beginning-up raised £5m in funding from buyers together with Notion Capital, Triple Level Ventures and Speedinvest two years in the past, following an preliminary pre-seed spherical led by Ardour Capital.
Fertifa is the unique supplier of the insurer Aviva UK’s household planning and fertility profit for a lot of of its healthcare schemes.
The beginning-up’s providing is predicated on a per-employee, per-month pricing mannequin, and gives reimbursement administration by charging a 5% charge on transaction volumes.
It has additionally broadened its providers lately by including males’s well being, neurodiversity assist and a cost plan permitting workers to keep away from up-front prices.
Juniper, which was based by Ambra Zhang and Max Bacon, was set as much as handle a niche within the non-public medical insurance coverage (PMI) market by specializing in reproductive well being protection.
It additionally raised funding from exterior buyers, together with Insurtech Gateway and 2100.
The speedy development of personal fertility service suppliers has given rise to larger scrutiny of their practices, with the collapse of Apricity, one distinguished firm within the sector, on the finish of final yr leaving some IVF sufferers 1000’s of kilos out of pocket and asking questions in regards to the unregulated nature of the business.
On the time, a press release from the Human Fertilisation and Embryology Authority (HFEA) stated it might “solely regulate UK licensed fertility clinics, that are the premises the place therapies happen”.
“The choice to stop buying and selling was taken by Apricity’s board,” it added.
“The HFEA is unable to assist sufferers get hold of a refund nor compensation.
“Sufferers can even contact the licenced clinic the place any procedures, comparable to egg assortment, had been attributable to happen.
“We might anticipate Apricity to make sure that any eggs, sperm or embryos saved within the UK are sorted.”
Learn extra from Sky Information:
Chancellor considering ‘changes’ to ISAs
Most important part of Reeves’s speech was what wasn’t said
HMRC doesn’t know how many billionaires pay tax in the UK
One market supply stated that Fertifa’s acquisition of Juniper would strengthen its place as an rising chief within the sector.
Different company offers within the business have included Nasdaq-listed Progyny’s buy of Apryl, a Berlin-based fertility advantages platform, in June 2024.
Ms Burbidge and Juniper declined to touch upon the deal on Wednesday forward of a proper announcement.
